Mycoplasma genitalium is an important sexually transmitted pathogen that affects both men and women. In genital-mucosal tissues, it initiates colonization of epithelial cells by attaching itself to host cells via several identified bacterial ligands and host cell surface receptors. We have previously shown that a mutant form of M. genitalium lacking methionine sulfoxide reductase A (MsrA), an antioxidant enzyme which converts oxidized methionine (Met(O)) into methionine (Met), shows decreased viability in infected animals. To gain more insights into the mechanisms by which MsrA controls M. genitalium virulence, we compared the wild-type M. genitalium strain (G37) with an msrA mutant (MS5) strain for their ability to interact with target cervical epithelial cell lines (HeLa and C33A) and THP-1 monocytic cells. Infection of epithelial cell lines with both strains revealed that MS5 was less cytotoxic to HeLa and C33A cell lines than the G37 strain. Also, the MS5 strain was more susceptible to phagocytosis by THP-1 cells than wild type strain (G37). Further, MS5 was less able to induce aggregation and differentiation in THP-1 cells than the wild type strain, as determined by carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling of the cells, followed by counting of cells attached to the culture dish using image analysis. Finally, MS5 was observed to induce less proinflammatory cytokine TNF-α by THP-1 cells than wild type G37 strain. These results indicate that MsrA affects the virulence properties of M. genitalium by modulating its interaction with host cells.
References
[1]
Falk L, Fredlund H, Jensen JS (2005) Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 81: 73–78.
[2]
Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC (2009) Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 36: 598–606.
[3]
Taylor-Robinson D, Gilroy CB, Thomas BJ, Hay PE (2004) Mycoplasma genitalium in chronic non-gonococcal urethritis. Int J STD AIDS 15: 21–25.
[4]
Short VL, Totten PA, Ness RB, Astete SG, Kelsey SF, et al. (2009) Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis 48: 41–47.
[5]
Short VL, Totten PA, Ness RB, Astete SG, Kelsey SF, et al. (2009) The demographic, sexual health and behavioural correlates of Mycoplasma genitalium infection among women with clinically suspected pelvic inflammatory disease. Sex Transm Infect 86: 29–31.
[6]
Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, et al. (2002) Association between Mycoplasma genitalium and acute endometritis. Lancet 359: 765–766.
[7]
Napierala Mavedzenge S, Weiss HA (2009) Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis. AIDS 23: 611–620.
[8]
Baseman JB, Reddy SP, Dallo SF (1996) Interplay between mycoplasma surface proteins, airway cells, and the protean manifestations of mycoplasma-mediated human infections. Am J Respir Crit Care Med 154: S137–144.
[9]
Reddy SP, Rasmussen WG, Baseman JB (1995) Molecular cloning and characterization of an adherence-related operon of Mycoplasma genitalium. J Bacteriol 177: 5943–5951.
[10]
Dhandayuthapani S, Rasmussen WG, Baseman JB (1999) Disruption of gene mg218 of Mycoplasma genitalium through homologous recombination leads to an adherence-deficient phenotype. Proc Natl Acad Sci U S A 96: 5227–5232.
[11]
Pich OQ, Burgos R, Ferrer-Navarro M, Querol E, Pinol J (2008) Role of Mycoplasma genitalium MG218 and MG317 cytoskeletal proteins in terminal organelle organization, gliding motility and cytadherence. Microbiology 154: 3188–3198.
[12]
Baseman JB, Lange M, Criscimagna NL, Giron JA, Thomas CA (1995) Interplay between mycoplasmas and host target cells. Microb Pathog 19: 105–116.
[13]
Dallo SF, Baseman JB (2000) Intracellular DNA replication and long-term survival of pathogenic mycoplasmas. Microb Pathog 29: 301–309.
[14]
You X, Wu Y, Zeng Y, Deng Z, Qiu H, et al. (2008) Mycoplasma genitalium-derived lipid-associated membrane proteins induce activation of MAPKs, NF-kappaB and AP-1 in THP-1 cells. FEMS Immunol Med Microbiol 52: 228–236.
[15]
You XX, Zeng YH, Wu YM (2006) Interactions between mycoplasma lipid-associated membrane proteins and the host cells. J Zhejiang Univ Sci B 7: 342–350.
[16]
Wu Y, Qiu H, Zeng Y, You X, Deng Z, et al. (2008) Mycoplasma genitalium lipoproteins induce human monocytic cell expression of proinflammatory cytokines and apoptosis by activating nuclear factor kappaB. Mediators Inflamm 2008: 195427.
[17]
Nathan C, Shiloh MU (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 97: 8841–8848.
[18]
Babior BM, Lambeth JD, Nauseef W (2002) The neutrophil NADPH oxidase. Arch Biochem Biophys 397: 342–344.
[19]
Hampton MB, Kettle AJ, Winterbourn CC (1998) Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 92: 3007–3017.
[20]
Rey P, Cuine S, Eymery F, Garin J, Court M, et al. (2005) Analysis of the proteins targeted by CDSP32, a plastidic thioredoxin participating in oxidative stress responses. Plant J 41: 31–42.
[21]
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87: 1620–1624.
[22]
Nathan CF, Ehrt S (2004) Nitric Oxide in Tuberculosis. In: Rom W, Garay S, editors. Tuberculosis. 2nd ed. Philadelphia: Lippincott, Williams and Wilkins. pp. 215–235.
[23]
Saikolappan S, Sasindran SJ, Yu HD, Baseman JB, Dhandayuthapani S (2009) The Mycoplasma genitalium MG_454 gene product resists killing by organic hydroperoxides. J Bacteriol 191: 6675–6682.
[24]
Weissbach H, Etienne F, Hoshi T, Heinemann SH, Lowther WT, et al. (2002) Peptide methionine sulfoxide reductase: structure, mechanism of action, and biological function. Arch Biochem Biophys 397: 172–178.
[25]
Grimaud R, Ezraty B, Mitchell JK, Lafitte D, Briand C, et al. (2001) Repair of oxidized proteins. Identification of a new methionine sulfoxide reductase. J Biol Chem 276: 48915–48920.
[26]
Kumar RA, Koc A, Cerny RL, Gladyshev VN (2002) Reaction mechanism, evolutionary analysis, and role of zinc in Drosophila methionine-R-sulfoxide reductase. J Biol Chem 277: 37527–37535.
[27]
Lowther WT, Weissbach H, Etienne F, Brot N, Matthews BW (2002) The mirrored methionine sulfoxide reductases of Neisseria gonorrhoeae pilB. Nat Struct Biol 9: 348–352.
[28]
Rodrigo MJ, Moskovitz J, Salamini F, Bartels D (2002) Reverse genetic approaches in plants and yeast suggest a role for novel, evolutionarily conserved, selenoprotein-related genes in oxidative stress defense. Mol Genet Genomics 267: 613–621.
[29]
Boschi-Muller S, Olry A, Antoine M, Branlant G (2005) The enzymology and biochemistry of methionine sulfoxide reductases. Biochim Biophys Acta 1703: 231–238.
[30]
Weissbach H, Resnick L, Brot N (2005) Methionine sulfoxide reductases: history and cellular role in protecting against oxidative damage. Biochim Biophys Acta 1703: 203–212.
[31]
Sasindran SJ, Saikolappan S, Dhandayuthapani S (2007) Methionine sulfoxide reductases and virulence of bacterial pathogens. Future Microbiol 2: 619–630.
[32]
Ezraty B, Aussel L, Barras F (2005) Methionine sulfoxide reductases in prokaryotes. Biochim Biophys Acta 1703: 221–229.
[33]
Mintz KP, Moskovitz J, Wu H, Fives-Taylor PM (2002) Peptide methionine sulfoxide reductase (MsrA) is not a major virulence determinant for the oral pathogen Actinobacillus actinomycetemcomitans. Microbiology 148: 3695–3703.
[34]
Lee WL, Gold B, Darby C, Brot N, Jiang X, et al. (2009) Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite. Mol Microbiol 71: 583–593.
[35]
Alamuri P, Maier RJ (2004) Methionine sulphoxide reductase is an important antioxidant enzyme in the gastric pathogen Helicobacter pylori. Mol Microbiol 53: 1397–1406.
[36]
Dhandayuthapani S, Blaylock MW, Bebear CM, Rasmussen WG, Baseman JB (2001) Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium. J Bacteriol 183: 5645–5650.
[37]
Douglas T, Daniel DS, Parida BK, Jagannath C, Dhandayuthapani S (2004) Methionine sulfoxide reductase A (MsrA) deficiency affects the survival of Mycobacterium smegmatis within macrophages. J Bacteriol 186: 3590–3598.
[38]
Hassouni ME, Chambost JP, Expert D, Van Gijsegem F, Barras F (1999) The minimal gene set member msrA, encoding peptide methionine sulfoxide reductase, is a virulence determinant of the plant pathogen Erwinia chrysanthemi. Proc Natl Acad Sci U S A 96: 887–892.
[39]
Moskovitz J, Rahman MA, Strassman J, Yancey SO, Kushner SR, et al. (1995) Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage. J Bacteriol 177: 502–507.
[40]
Singh VK, Jayaswal RK, Wilkinson BJ (2001) Cell wall-active antibiotic induced proteins of Staphylococcus aureus identified using a proteomic approach. FEMS Microbiol Lett 199: 79–84.
[41]
Vattanaviboon P, Seeanukun C, Whangsuk W, Utamapongchai S, Mongkolsuk S (2005) Important role for methionine sulfoxide reductase in the oxidative stress response of Xanthomonas campestris pv. phaseoli. J Bacteriol 187: 5831–5836.
[42]
Denkel LA, Horst SA, Rouf SF, Kitowski V, Bohm OM, et al. (2011) Methionine sulfoxide reductases are essential for virulence of Salmonella typhimurium. PLoS One 6: e26974.
[43]
Wizemann TM, Moskovitz J, Pearce BJ, Cundell D, Arvidson CG, et al. (1996) Peptide methionine sulfoxide reductase contributes to the maintenance of adhesins in three major pathogens. Proc Natl Acad Sci U S A 93: 7985–7990.
[44]
Giomarelli B, Visai L, Hijazi K, Rindi S, Ponzio M, et al. (2006) Binding of Streptococcus gordonii to extracellular matrix proteins. FEMS Microbiol Lett 265: 172–177.
[45]
Herzberg MC, Nobbs A, Tao L, Kilic A, Beckman E, et al. (2005) Oral streptococci and cardiovascular disease: searching for the platelet aggregation-associated protein gene and mechanisms of Streptococcus sanguis-induced thrombosis. J Periodontol 76: 2101–2105.
[46]
Beloin C, Valle J, Latour-Lambert P, Faure P, Kzreminski M, et al. (2004) Global impact of mature biofilm lifestyle on Escherichia coli K-12 gene expression. Mol Microbiol 51: 659–674.
[47]
Kuboniwa M, Tribble GD, James CE, Kilic AO, Tao L, et al. (2006) Streptococcus gordonii utilizes several distinct gene functions to recruit Porphyromonas gingivalis into a mixed community. Mol Microbiol 60: 121–139.
[48]
Mei JM, Nourbakhsh F, Ford CW, Holden DW (1997) Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol Microbiol 26: 399–407.
[49]
Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1: 1112–1116.
[50]
Clanchy FI, Holloway AC, Lari R, Cameron PU, Hamilton JA (2006) Detection and properties of the human proliferative monocyte subpopulation. J Leukoc Biol 79: 757–766.
[51]
Campbell P, Canono B, Drevets D (1994) Measurement of bacterial ingestion and killing by macrophages. Current Protocols in immunology: Wiley online library. pp. 14.51–14.16.13.
[52]
Medina E, Goldmann O (2011) In vivo and ex vivo protocols for measuring the killing of extracellular pathogens by macrophages. Curr Protoc Immunol Chapter 14: Unit 14 19 11–17.
[53]
Razin S (1983) Cell lysis and Isolation of Membranes. In: Razin S, Tully JG, editors. Methods in Mycoplasmology. New York: Academic Press. pp. 22–233.
[54]
Ausubel F, Brent R, Kingston R, Moore D, Seidman J, et al. (1989) Current Prtocols in Molecular Biology. New York: Wiley.
[55]
Balasubramanian S, Kannan TR, Hart PJ, Baseman JB (2009) Amino acid changes in elongation factor Tu of Mycoplasma pneumoniae and Mycoplasma genitalium influence fibronectin binding. Infect Immun 77: 3533–3541.
[56]
Wayne KJ, Sham LT, Tsui HC, Gutu AD, Barendt SM, et al. (2010) Localization and cellular amounts of the WalRKJ (VicRKX) two-component regulatory system proteins in serotype 2 Streptococcus pneumoniae. J Bacteriol 192: 4388–4394.
[57]
Somerson NL, Walls BE, Chanock RM (1965) Hemolysin of Mycoplasma pneumoniae: tentative identification as a peroxide. Science 150: 226–228.
[58]
Vilei EM, Frey J (2001) Genetic and biochemical characterization of glycerol uptake in mycoplasma mycoides subsp. mycoides SC: its impact on H(2)O(2) production and virulence. Clin Diagn Lab Immunol 8: 85–92.
[59]
McGowin CL, Popov VL, Pyles RB (2009) Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. BMC Microbiol 9: 139.
[60]
Lahiri A, Das P, Chakravortty D (2008) The LysR-type transcriptional regulator Hrg counteracts phagocyte oxidative burst and imparts survival advantage to Salmonella enterica serovar Typhimurium. Microbiology 154: 2837–2846.
[61]
Reyes L, Davidson MK, Thomas LC, Davis JK (1999) Effects of Mycoplasma fermentans incognitus on differentiation of THP-1 cells. Infect Immun 67: 3188–3192.
[62]
Dumke R, Hausner M, Jacobs E (2011) Role of Mycoplasma pneumoniae glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mediating interactions with the human extracellular matrix. Microbiology 157: 2328–2338.
[63]
Pilo P, Vilei EM, Peterhans E, Bonvin-Klotz L, Stoffel MH, et al. (2005) A metabolic enzyme as a primary virulence factor of Mycoplasma mycoides subsp. mycoides small colony. J Bacteriol 187: 6824–6831.
[64]
Hames C, Halbedel S, Hoppert M, Frey J, Stulke J (2009) Glycerol metabolism is important for cytotoxicity of Mycoplasma pneumoniae. J Bacteriol 191: 747–753.
[65]
Vilei EM, Abdo EM, Nicolet J, Botelho A, Goncalves R, et al. (2000) Genomic and antigenic differences between the European and African/Australian clusters of Mycoplasma mycoides subsp. mycoides SC. Microbiology 146(Pt 2): 477–486.
[66]
Bischof DF, Janis C, Vilei EM, Bertoni G, Frey J (2008) Cytotoxicity of Mycoplasma mycoides subsp. mycoides small colony type to bovine epithelial cells. Infect Immun 76: 263–269.
[67]
Fraser CM, Gocayne JD, White O, Adams MD, Clayton RA, et al. (1995) The minimal gene complement of Mycoplasma genitalium. Science 270: 397–403.
[68]
Jensen JS, Blom J, Lind K (1994) Intracellular location of Mycoplasma genitalium in cultured Vero cells as demonstrated by electron microscopy. Int J Exp Pathol 75: 91–98.
[69]
Zeng Y, Wu Y, Deng Z, You X, Zhu C, et al. (2008) Apoptosis induced by lipid-associated membrane proteins from Mycoplasma penetrans is mediated by nuclear factor kappaB activation in mouse macrophage. Can J Microbiol 54: 150–158.
[70]
He J, You X, Zeng Y, Yu M, Zuo L, et al. (2009) Mycoplasma genitalium-derived lipid-associated membrane proteins activate NF-kappaB through toll-like receptors 1, 2, and 6 and CD14 in a MyD88-dependent pathway. Clin Vaccine Immunol 16: 1750–1757.
[71]
McGowin CL, Ma L, Martin DH, Pyles RB (2009) Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells. Infect Immun 77: 1175–1181.
[72]
Zuo LL, Wu YM, You XX (2009) Mycoplasma lipoproteins and Toll-like receptors. J Zhejiang Univ Sci B 10: 67–76.
[73]
Skaar EP, Tobiason DM, Quick J, Judd RC, Weissbach H, et al. (2002) The outer membrane localization of the Neisseria gonorrhoeae MsrA/B is involved in survival against reactive oxygen species. Proc Natl Acad Sci U S A 99: 10108–10113.
[74]
Ward J, Fletcher J, Nair SP, Wilson M, Williams RJ, et al. (2001) Identification of the exported proteins of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans by using alkaline phosphatase fusions. Infect Immun 69: 2748–2752.
[75]
Cao P, McClain MS, Forsyth MH, Cover TL (1998) Extracellular release of antigenic proteins by Helicobacter pylori. Infect Immun 66: 2984–2986.
